Skip to content

Drug interactions

Daclatasvir + Ethinyl estradiol-drospirenone

Severity: Minor

Daclatasvir and Ethinyl estradiol-drospirenone: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Daclatasvir is a CYP3A4 substrate, but drospirenone is not a relevant inhibitor, so no meaningful change in exposure is expected. Daclatasvir has not been shown to compromise combined contraceptive efficacy.

What this interaction means in plain words

Daclatasvir and Ethinyl estradiol-drospirenone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Daclatasvir belongs to Anti Virals; Ethinyl estradiol-drospirenone belongs to Endocrine.

Evidence level: Low

Why it happens

Theoretical weak CYP3A4 inhibition; not clinically established.

What to do

No adjustment is needed.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Daclatasvir and Ethinyl estradiol-drospirenone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Daclatasvir with Ethinyl estradiol-drospirenone?

MediHelp rates the interaction as minor. Daclatasvir and Ethinyl estradiol-drospirenone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Daclatasvir is a CYP3A4 substrate, but drospirenone is not a relevant inhibitor, so no meaningful change in exposure is expected. Daclatasvir has not been shown to compromise combined contraceptive efficacy.

How serious is the interaction between Daclatasvir and Ethinyl estradiol-drospirenone?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No adjustment is needed.

What other medicines interact with Ethinyl estradiol-drospirenone?

MediHelp also lists interactions of Ethinyl estradiol-drospirenone with, for example, Fezolinetant, Ombitasvir / paritaprevir / ritonavir, Ombitasvir / paritaprevir / ritonavir and dasabuvir. The full list is on the Ethinyl estradiol-drospirenone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in